Townhall + Tv

Empowering Africa Through Africapitalism | Tony Elumelu, Founder, Heirs Holdings. 00:10:00

Tony Elumelu, a leading African investor and philanthropist, is the founder of Heirs Holdings and the Tony Elumelu Foundation. Through Africapitalism, he promotes the private sector and entrepreneurship as catalysts for Africa's social and economic development. Recognized globally, including by President Obama and TIME magazine, Elumelu emphasizes long-term investment in critical sectors to drive inclusive and sustainable prosperity across Africa.

Empowering Africa Through Africapitalism | Tony Elumelu, Founder, Heirs Holdings. 00:10:00

Recent Videos

Thomas Olin Highlights Kancera’s Latest Advances and Strategic Focus | Dr. Thomas Olin, CEO , Kancera AB.

Pablo Pereiro Discusses Squirrel Media’s 63% Profit Growth and 14.7% Stock Surge | Pablo Pereiro , CEO , Squirrel Media SA.

Steve Oliver of musicMagpie Discusses Circular Economy and Company's Growth Strategy | Steve Oliver , CEO , musicMagpie PLC.

Revolutionizing Healing with Naturally Derived Psychedelics | Benjamin Lightburn, CEO , Filament Health Corp.

SMC Global Securities Launches New Office at Bahu Plaza, Jammu, to Promote Share Market Investments | Ajay Garg , CEO , SMC Global Securities Ltd.

Exploring Demoralization Syndrome Treatment with Filament Health’s Psilocybin Trials | Benjamin Lightburn, CEO , Filament Health Corp.

BioInvent CEO Explores Portfolio Strategy and Upcoming Breakthroughs | Dr. Martin Welschof, CEO , BioInvent International AB.

Piotr Figarski Discusses Image Power's 2022 Results and Future Trends | Piotr Figarski, Vice President , Image Power SA.

Pablo Pereiro and María Bonaria Fois Discuss Squirrel Media's Strategic Acquisition of Mondo TV Studios | Pablo Pereiro , CEO , Squirrel Media SA.

Lexington Gold Set to List on London AIM Exchange After Reverse Takeover | Dr. Bernard Olivier, CEO , Lexington Gold Ltd.

Thomas Olin, CEO of Kancera AB, Discusses Strategic Advances in Biopharma Innovation | Dr. Thomas Olin, CEO , Kancera AB.

Leading the Charge in the Psychedelic Movement with Filament Health | Benjamin Lightburn, CEO , Filament Health Corp.

Pini Mandel on the Power of Dynamic Pricing to Boost Retail KPIs and Customer Satisfaction | Pini Mandel , CEO , Quicklizard Ltd.

Jean Michel Ng Tseung, New CEO of MCB Group, Shares Vision for a Sustainable Future | Jean Michel Ng Tseung , CEO , MCB Group Ltd.

Viktor Garmiani Unveils Candles Scandinavia’s Q4 Report Highlights | Viktor Garmiani, CEO , Candles Scandinavia AB.

Squirrel Media's Record-Breaking Year: CEO Pablo Pereiro Discusses Key Strategies and Global Expansion | Pablo Pereiro , CEO , Squirrel Media SA.

Suggestions

Five Questions with Jan Bredack, CEO of Veganz Group AG | Jan Bredack, CEO , Veganz Group AG.

Samsara CEO Sanjit Biswas joins 'TechCheck' to discuss the company's recent IPO and the impact of spiking growth rates.

Mastering the Advanced Financial Modeler (AFM) Accreditation: What You Need to Know | Ian Schnoor, Executive Director ,Financial Modeling Institute.

JLL CEO Discusses Long-Term Outlook for Office Space Amidst Changing Work Dynamics | Christian Ulbrich, CEO, JLL Partners.

invest and support founders from seed until the later stages|Katie Bullard,Managing Director,Insight Partners

At bpost Group, the collective dedication of over 34,000 employees worldwide drives daily efforts to foster growth and excellence in service provision.|Chris Peeters is CEO of bpostgroup

Axiom Group Introduces NRG Xcite System for Exploration at PDAC

Bauxite Mining and Logistics: An Overview of Our Unique Project in Guinea

Exploring the Future of Copper: A Conversation with David Kelley, CEO of Chakana Copper Corp. | DAVID KELLEY, CEO of Chakana Copper Corporation

Conversation on Development Finance and Africa's Role in Global Investments | Tellef Thorleifsson, CEO, Norfund.

Dr. Bennie Jeng, Cornea expert, Chair of the Department of Ophthalmology

Biopharmaceutical CEO discusses promising Phase 3 trial results of a novel antibiotic for Clostridioides difficile Infections with potential market impact exceeding $1B |David P Luci , CEO, Acurx Pharmaceuticals Inc.